Literature DB >> 29944844

Reply to Voelkel and Newman: The Light at the End of the Long Pulmonary Hypertension Tunnel Brightens.

Jason M Elinoff1, Marc Humbert2,3,4,5, Michael A Solomon1,6.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29944844      PMCID： PMC6222461          DOI： 10.1164/rccm.201804-0792LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

1.  Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.

Authors:  Anna R Hemnes; Aaron W Trammell; Stephen L Archer; Stuart Rich; Chang Yu; Hui Nian; Niki Penner; Mitchell Funke; Lisa Wheeler; Ivan M Robbins; Eric D Austin; John H Newman; James West
Journal:  Circulation       Date:  2014-10-31       Impact factor: 29.690

2.  Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension.

Authors:  Yuichi Tamura; Carole Phan; Ly Tu; Morane Le Hiress; Raphaël Thuillet; Etienne-Marie Jutant; Elie Fadel; Laurent Savale; Alice Huertas; Marc Humbert; Christophe Guignabert
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

3.  Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension.

Authors:  Rennie L Rhee; Nicole B Gabler; Sapna Sangani; Amy Praestgaard; Peter A Merkel; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2015-11-01       Impact factor: 21.405

4.  Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Authors:  Jason M Elinoff; Richa Agarwal; Christopher F Barnett; Raymond L Benza; Michael J Cuttica; Ahmed M Gharib; Michael P Gray; Paul M Hassoun; Anna R Hemnes; Marc Humbert; Todd M Kolb; Tim Lahm; Jane A Leopold; Stephen C Mathai; Vallerie V McLaughlin; Ioana R Preston; Erika B Rosenzweig; Oksana A Shlobin; Virginia D Steen; Roham T Zamanian; Michael A Solomon
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

5.  Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial.

Authors:  Samar Farha; Didem Saygin; Margaret M Park; Hoi I Cheong; Kewal Asosingh; Suzy Aa Comhair; Olivia R Stephens; Emir C Roach; Jacqueline Sharp; Kristin B Highland; Frank P DiFilippo; Donald R Neumann; W H Wilson Tang; Serpil C Erzurum
Journal:  JCI Insight       Date:  2017-08-17

6.  Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.

Authors:  Tufik R Assad; Anna R Hemnes; Emma K Larkin; Andrew M Glazer; Meng Xu; Quinn S Wells; Eric H Farber-Eger; Quanhu Sheng; Yu Shyr; Frank E Harrell; John H Newman; Evan L Brittain
Journal:  J Am Coll Cardiol       Date:  2016-12-13       Impact factor: 24.094

7.  Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.

Authors:  Raymond L Benza; Mardi Gomberg-Maitland; Teresa Demarco; Adaani E Frost; Adam Torbicki; David Langleben; Tomas Pulido; Priscilla Correa-Jaque; Michael J Passineau; Howard W Wiener; Mayumi Tamari; Tomomitsu Hirota; Michiaki Kubo; Hemant K Tiwari
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

8.  Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.

Authors:  Evangelos D Michelakis; Vikram Gurtu; Linda Webster; Gareth Barnes; Geoffrey Watson; Luke Howard; John Cupitt; Ian Paterson; Richard B Thompson; Kelvin Chow; Declan P O'Regan; Lan Zhao; John Wharton; David G Kiely; Adam Kinnaird; Aristeidis E Boukouris; Chris White; Jayan Nagendran; Darren H Freed; Stephen J Wort; J Simon R Gibbs; Martin R Wilkins
Journal:  Sci Transl Med       Date:  2017-10-25       Impact factor: 17.956

9.  A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial.

Authors:  Jason M Elinoff; J Eduardo Rame; Paul R Forfia; Mary K Hall; Junfeng Sun; Ahmed M Gharib; Khaled Abd-Elmoniem; Grace Graninger; Bonnie Harper; Robert L Danner; Michael A Solomon
Journal:  Trials       Date:  2013-04-02       Impact factor: 2.279

10.  Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Authors:  Stefan Gräf; Matthias Haimel; Marta Bleda; Charaka Hadinnapola; Laura Southgate; Wei Li; Joshua Hodgson; Bin Liu; Richard M Salmon; Mark Southwood; Rajiv D Machado; Jennifer M Martin; Carmen M Treacy; Katherine Yates; Louise C Daugherty; Olga Shamardina; Deborah Whitehorn; Simon Holden; Micheala Aldred; Harm J Bogaard; Colin Church; Gerry Coghlan; Robin Condliffe; Paul A Corris; Cesare Danesino; Mélanie Eyries; Henning Gall; Stefano Ghio; Hossein-Ardeschir Ghofrani; J Simon R Gibbs; Barbara Girerd; Arjan C Houweling; Luke Howard; Marc Humbert; David G Kiely; Gabor Kovacs; Robert V MacKenzie Ross; Shahin Moledina; David Montani; Michael Newnham; Andrea Olschewski; Horst Olschewski; Andrew J Peacock; Joanna Pepke-Zaba; Inga Prokopenko; Christopher J Rhodes; Laura Scelsi; Werner Seeger; Florent Soubrier; Dan F Stein; Jay Suntharalingam; Emilia M Swietlik; Mark R Toshner; David A van Heel; Anton Vonk Noordegraaf; Quinten Waisfisz; John Wharton; Stephen J Wort; Willem H Ouwehand; Nicole Soranzo; Allan Lawrie; Paul D Upton; Martin R Wilkins; Richard C Trembath; Nicholas W Morrell
Journal:  Nat Commun       Date:  2018-04-12       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.